Serum micro-RNAs with mutation-targeted RNA modification: a potent cancer detection tool constructed using an

Wei Liao1, Yuyan Xu2, Mingxin Pan3

  • 1Department of Hepatobiliary Surgery, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.

Scientific Reports
|April 19, 2024
PubMed

Insights

Researchers identified RNA modification-related microRNAs (miRNAs) linked to cancer. A machine learning model using these miRNAs achieved high accuracy in detecting various cancers, including early stages, offering a potential new screening tool.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • RNA modifications are crucial in biological processes and disease, with micro-RNAs (miRNAs) playing a key role.
  • Genetic variants targeting RNA modifications in miRNAs can significantly alter their function and impact cancer development.

Purpose of the Study:

  • To investigate the association between RNA modification-related miRNA variants (RMvar-related miRNAs) and tumorigenesis.
  • To develop a cancer-specific diagnostic signature using RMvar-related miRNAs and machine learning.

Main Methods:

  • Utilized an optimized machine learning workflow combining LASSO, RFE, and nine ML algorithms.
  • Screened 504 serum RMvar-related miRNAs to identify candidate biomarkers.
  • Constructed and validated a diagnostic signature using a large cohort of 43,047 clinical samples.

Main Results:

  • The developed signature demonstrated exceptional diagnostic performance: AUC of 0.998, 93.1% specificity, and 99.3% sensitivity in the validation cohort.
  • The signature showed satisfactory diagnostic capabilities across various cancers and conditions.
  • Successfully distinguished early-stage tumors, highlighting its potential for early cancer detection.

Conclusions:

  • RMvar-related miRNAs are closely associated with tumor development.
  • The proposed miRNA-based signature serves as an effective tool for cancer screening and early detection.